|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR-OO-13003311 |
|
最近更新日期: Date of Last Refreshed on: |
2016-02-10 21:07:46 |
|
注册时间: Date of Registration: |
2013-07-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
建立中国的心死亡器官捐献规范化模式 |
|
Public title: |
Constrction of Chinese DCD standardized model |
|
注册题目简写: |
中国DCD器官捐献规范化模式 |
|
English Acronym: |
Chinese DCD standardized model |
|
研究课题的正式科学名称: |
建立中国的心死亡器官捐献规范化模式 |
|
Scientific title: |
Constrction of Chinese DCD standardized model |
|
研究课题代号(代码): Study subject ID: |
201302009 |
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
昌盛 |
研究负责人: |
陈孝平 |
|
Applicant: |
Sheng Chang |
Study leader: |
Xiao-ping Chen |
|
申请注册联系人电话: Applicant telephone: |
+86 18607198501 |
研究负责人电话:
Study leader's |
+86 027-83665283 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
changsheng2000@126.com |
研究负责人电子邮件: Study leader's E-mail: |
qgyzlc@tjh.tjmu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
湖北省武汉市硚口区解放大道1095号 |
研究负责人通讯地址: |
湖北省武汉市硚口区解放大道1095号 |
|
Applicant address: |
1095 Jiefang Avenue, Wuhan, Hubei, China |
Study leader's address: |
1095 Jiefang Avenue, Wuhan, Hubei, China |
|
申请注册联系人邮政编码: Applicant postcode: |
430030 |
研究负责人邮政编码: Study leader's postcode: |
430030 |
|
申请人所在单位: |
湖北省武汉市同济医院器官移植研究所 |
||
|
Applicant's institution: |
Institute of Organ Transplantation, Tongji Hospital, Wuhan, Hubei |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
tj2012.12.24 |
伦理委员会批件附件: Approved file of Ethical Committee: |
|
|
批准本研究的伦理委员会名称: |
华中科技大学同济医学院附属同济医院伦理委员会 |
||
|
Name of the ethic committee: |
The Ethical Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2012-12-24 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
华中科技大学同济医学院附属同济医院器官移植研究所 |
||
|
Primary sponsor: |
Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
||
|
研究实施负责(组长)单位地址: |
湖北省武汉市硚口区解放大道1095号 |
||
|
Primary sponsor's address: |
1095 Jiefang Avenue, Wuhan, Hubei, China |
||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|||
|
经费或物资来源: |
中国卫生部2013年卫生行业科研专项经费 |
||
|
Source(s) of funding: |
The special funds of health research 2013, MOH, China |
||
|
研究疾病: |
器官移植 |
||
|
Target disease: |
Organ Transplantation |
||
|
研究疾病代码: |
|
||
|
Target disease code: |
|
||
|
研究类型: |
观察性研究 |
||
|
Study type: |
Observational study |
||
|
研究所处阶段: |
其它 | ||
|
Study phase: |
N/A |
||
|
研究设计: |
单臂 |
||
|
Study design: |
Single arm |
||
|
研究目的: |
建立适合中国DBCD模式的撤除治疗时机选择评价体系;建立潜在的DCD供者濒死期规范化治疗方案和质量控制体系;制定潜在的DBCD供者器官维护及获取的标准化方案。 |
||
|
Objectives of Study: |
Construction of evaluation system on the timing of treatment removal for DBCD donor retaining Chinese characteristics; Construction of quality control system and standard treatment protocol on the potential DCD donor in the agonal stage; Constitution of standard protocol on organ procument and maintaince in the potential DCD donor. |
||
|
药物成份或治疗方案详述: |
|
||
|
Description for medicine or protocol of treatment in detail: |
|
||
|
纳入标准: |
1. 自愿参加并签署知情同意书 2. 年龄为0~70,性别不限 3. 愿意进行器官捐献的潜在供者 |
||
|
Inclusion criteria |
1. agree to participate in this study and give informed consent; 2. age 0-70 years old, both male and female; 3. the potential donor. |
||
|
排除标准: |
1. 热缺血时间大于30分钟 2.冷却血时间大于或等于24小时 3. 不能配合临床试验人员完成相关检查者 4,供者存在传染性疾病(HBV,HCV,AIDS) 5. 其它临床试验人员认为应排除的情况 |
||
|
Exclusion criteria: |
1. the warm ischemic time>30min; 2. the cold ischemic time>24hours; 3. fail to complete the related examinations; 4. donor with HBV,HCV,and AIDS; 5. other situations that should be excluded into this study. |
|
研究实施时间: Study execute time: |
从 From 2013-05-01 00:00:00至 To 2015-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2013-05-01 00:00:00 至 To 2015-12-31 00:00:00 |
|
干预措施: Interventions: |
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
患者家属知情同意后,分配至无干预组或接受干预组 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
After get an informed consent, the donors will be divided into the intervention group or no treatmen |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
|
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
华中科技大学同济医学院附属同济医院器官移植研究所 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
华中科技大学同济医学院附属同济医院器官移植研究所 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |